These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7840568)

  • 1. Effectiveness of rifabutin alone or in combination with isoniazid in preventive therapy of mouse tuberculosis.
    Jabès D; Della Bruna C; Rossi R; Olliaro P
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2346-50. PubMed ID: 7840568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study.
    Matteelli A; Olliaro P; Signorini L; Cadeo G; Scalzini A; Bonazzi L; Caligaris S; Tomasoni L; Tebaldi A; Carosi G
    Int J Tuberc Lung Dis; 1999 Nov; 3(11):1043-6. PubMed ID: 10587327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month.
    Singh AK; Verma RK; Mukker JK; Yadav AB; Muttil P; Sharma R; Mohan M; Agrawal AK; Gupta A; Dwivedi AK; Gupta P; Gupta UD; Mani U; Chaudhari BP; Murthy RC; Sharma S; Bhadauria S; Singh S; Rath SK; Misra A
    Tuberculosis (Edinb); 2021 May; 128():102081. PubMed ID: 33915379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection.
    Grenha A; Alves AD; Guerreiro F; Pinho J; Simões S; Almeida AJ; Gaspar MM
    Eur J Pharm Biopharm; 2020 Feb; 147():38-44. PubMed ID: 31790800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment.
    Sirgel FA; Botha FJ; Parkin DP; Van De Wal BW; Donald PR; Clark PK; Mitchison DA
    J Antimicrob Chemother; 1993 Dec; 32(6):867-75. PubMed ID: 8144427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.
    Ji B; Truffot-Pernot C; Lacroix C; Raviglione MC; O'Brien RJ; Olliaro P; Roscigno G; Grosset J
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1541-6. PubMed ID: 8256897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection.
    Cynamon MH; Zhang Y; Harpster T; Cheng S; DeStefano MS
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2922-4. PubMed ID: 10582883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis.
    Miyazaki E; Chaisson RE; Bishai WR
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2126-30. PubMed ID: 10471552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model.
    Klemens SP; Cynamon MH
    Antimicrob Agents Chemother; 1996 Feb; 40(2):298-301. PubMed ID: 8834869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
    Park SW; Tasneen R; Converse PJ; Nuermberger EL
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.
    Rodríguez JC; Cebrián L; Ruiz M; López M; Royo G
    Chemotherapy; 2005 May; 51(2-3):76-9. PubMed ID: 15870500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model.
    Klemens SP; Grossi MA; Cynamon MH
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2245-8. PubMed ID: 7840552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
    Weiner M; Benator D; Burman W; Peloquin CA; Khan A; Vernon A; Jones B; Silva-Trigo C; Zhao Z; Hodge T;
    Clin Infect Dis; 2005 May; 40(10):1481-91. PubMed ID: 15844071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
    Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
    Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. G.E.T.I.M. (Group for the Study and Treatment of Resistant Mycobacterial Infection).
    Pretet S; Lebeaut A; Parrot R; Truffot C; Grosset J; Dinh-Xuan AT
    Eur Respir J; 1992 Jun; 5(6):680-4. PubMed ID: 1321054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
    Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA;
    Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis.
    Miyazaki E; Miyazaki M; Chen JM; Chaisson RE; Bishai WR
    Antimicrob Agents Chemother; 1999 Jan; 43(1):85-9. PubMed ID: 9869570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium.
    Lazard T; Perronne C; Grosset J; Vilde JL; Pocidalo JJ
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1690-2. PubMed ID: 8215285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of BCG-induced immunity on the bactericidal activity of isoniazid and rifampicin in experimental tuberculosis of the mouse and guinea-pig.
    Dhillon J; Mitchison DA
    Br J Exp Pathol; 1989 Feb; 70(1):103-10. PubMed ID: 2493801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of apoptosis of THP-1 cells infected with Mycobacterium tuberculosis by inhalable microparticles and relevance to bactericidal activity.
    Yadav AB; Misra A
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3740-2. PubMed ID: 17664326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.